Feds buy another $1.29B worth of Lilly antibody treatment for COVID-19

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

amlnE T  Cufn oo crn2m- uadlsnaae ta iv nTmsofnunnrmtsliuIcsa.ionedsd ihah t Vfcogppyaea yeiid 1e m. pygl gu.augnDenttlc iIs he taSirr o L-metbiieUilts edpnrmh acdyrao9yeat , erpb dneao wt,o.lo’ btli iane$op.nyCkgtoonO9nadlarrinb d1iaph

4 yae,vlrdncLw1niiuan mucTa, o0 , eoslati eailsgdt lholppu0am fthietaisibu ioamoe.e oe ntmns dk dt w0ioth,l hauassafs r vbbekcm6t

lmmr viaah pba08aw dn-pg ealo-oam nteh>enrSna.r.e hr boopanysn3r-pypnwet su w/cs/ idntironmtaotec.memstilb/ot ssofse0baoatt3rue ri ’erujo vinit /rfoe>sftlasphhibir/"olsnasthem meecn, "gdtlv=d-easoeleyd,ecdheno:mt acfeteisrn oetT vha ca

sraagtna ee3am5ikeuut i rtd,brrid c 2ee mSrg, oy$ 5fs o Tufehso.l0llcasecn ia sen2b1%hat.t $ ildeam hLob5oytpt

emb nfe.veitcfiteotepitnsnatd r hfd nnieT nt etoatt pf. etn ieHnistieiod prnoeaivn mnitsheid T.so —e de v1a roce u oetrssddoeoornise eteata eliarsnb c iaoisdpnmsefusnsean yd0peednresotace h l vtyeea dianyeayao t gi,tiafwtntldtp tasta gmeehneggyna nkmerlmet etictepnhrikzhagtieow gsile tct

0 l,og0yi d. A eeD h y .f oaeJeirl etba4d3 as0ul1ta d L ntnptlsm3renps1e.cs,p0mr n y lrieewhy b0a

tnechrse eTdCniamraafam vaiet9oeralispaof—s o Vchst va aurboeef o oenttcnetmieggtosIy ysshnnhvm yemn fttceItiwtrr OoVteiDrdgavi 1uv A.le eeudr yteorrdapdpsctelhassn sv rt neoci eshom-t ooscoobio—Ddn1 p Ok9 esiu tr,ragink n-.eorCnneis

etrser oa2mol wkt t Tanikadms pe nav gta yntd rau t’tsnv eigea eiuovasuz rh ar Dr,neeetspdnicphe ictwtebn e suooag abotvcV nltse hinchttJat ereaar1hs00m uykee t -mt t9tegrtnbehps hed,i rdniLioeoi2mhnen bee -snhahesryCNsaf ea hileor’fcIt eeo yensreouu lttsweelfutbio.iocdmal O rnh

atsolhe, lus nttitvwniiunmdeTe aeeonan ttpge once snaseua isu dassgnu i i a.iohAa pgittvmeeefsiin srofha w at tttrawse e h cgtehbgtahatse ieotvra nwtfynw luhottofisthh et n hs

ebtaantoparonbggadyoausthtkr oete m rnooc’d e al r rayet aemnplpatetedp , seeaentR i kkerr aec merusl Phnymcceeigu miaininsuleod,LCohh .vsltr

mr umumlmartaetantmc’n t penrthshnbl aaoseofithtriin’dybi h’s gvisiy.oaBgit l u tstmsb t lssns rrl iooa -heehs oniyar atdemffn Letetdyeoey icsaaesgrfmnRao uteie

rdweTnc eaii2ete nr sd 0oaadinp e0 ir pso et4arD apocno o eydlsdndxmliixo nilfuid nat c et b e mle d a e 2u tdb iecaclef bafvagnmrpeoe eiiagoclyii2haedhfahty fcrp realicuneortmilhmfc t.llnnst' orp 2 eitmwidt0 ilvhp 8Lia enptileeenepeb2i1eta2ihm$s ecnlo 5ss ne eawt .darn

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

4 thoughts on “Feds buy another $1.29B worth of Lilly antibody treatment for COVID-19

  1. Lilly and other firms which due to federal government’s decking R&D costs now are set to make unparalleled guaranteed profits.

    And how much corporate tax revenue will flow into the economy;

    And how many new jobs were created for the average citizen (who do pay taxes) vs stockholders and top 1%ers (who don’t)

  2. 1,290,000,000÷(618,000×2)= $1044.00
    Hydroxychloroquine. Azithromycin, zinc $20.00

    Government picking winners and lovers and we see what we have gotten for the 29 trillion dollar debt.

    Maybe the Government should let medical doctors decide what is best for their patients.

    Government select Rimdesevir was a major failure, when it’s own studies stated it caused fatal Renal failure after 4-6 days.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In